These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7515687)

  • 21. Characterization of monoclonal antibodies against apolipoproteins A-I and A-II. Epitope expression in LpA-I and LpA-I:A-II particles.
    Ulloa N; Bustos P; Castro G; Fruchart J; Vera M; Fruchart JC; Calvo C
    Hybridoma; 1999 Dec; 18(6):513-20. PubMed ID: 10626680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phospholipid transfer protein mediated conversion of high density lipoproteins generates pre beta 1-HDL.
    von Eckardstein A; Jauhiainen M; Huang Y; Metso J; Langer C; Pussinen P; Wu S; Ehnholm C; Assmann G
    Biochim Biophys Acta; 1996 Jun; 1301(3):255-62. PubMed ID: 8664337
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cholesterol efflux to high-density lipoproteins and apolipoprotein A-I phosphatidylcholine complexes is inhibited by ethanol: role of apolipoprotein structure and cooperative interaction of phosphatidylcholine and cholesterol.
    Avdulov NA; Chochina SV; Igbavboa U; Wood WG
    Biochemistry; 2000 Aug; 39(34):10599-606. PubMed ID: 10956052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure and function of apolipoprotein A-I and high-density lipoprotein.
    Segrest JP; Li L; Anantharamaiah GM; Harvey SC; Liadaki KN; Zannis V
    Curr Opin Lipidol; 2000 Apr; 11(2):105-15. PubMed ID: 10787171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms of high density lipoprotein-mediated efflux of cholesterol from cell plasma membranes.
    Phillips MC; Gillotte KL; Haynes MP; Johnson WJ; Lund-Katz S; Rothblat GH
    Atherosclerosis; 1998 Apr; 137 Suppl():S13-7. PubMed ID: 9694536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cellular cholesterol efflux.
    Fielding CJ; Fielding PE
    Biochim Biophys Acta; 2001 Oct; 1533(3):175-89. PubMed ID: 11731329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lecithin:cholesterol acyltransferase reaction on cellular lipid released by free apolipoprotein-mediated efflux.
    Czarnecka H; Yokoyama S
    Biochemistry; 1995 Apr; 34(13):4385-92. PubMed ID: 7703252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deletion of amino acids Glu146-->Arg160 in human apolipoprotein A-I (ApoA-ISeattle) alters lecithin:cholesterol acyltransferase activity and recruitment of cell phospholipid.
    Lindholm EM; Bielicki JK; Curtiss LK; Rubin EM; Forte TM
    Biochemistry; 1998 Apr; 37(14):4863-8. PubMed ID: 9538003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective down-regulation by protein kinase C inhibitors of apolipoprotein-mediated cellular cholesterol efflux in macrophages.
    Li Q; Tsujita M; Yokoyama S
    Biochemistry; 1997 Oct; 36(40):12045-52. PubMed ID: 9315842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-enzymatic glycosylation of apolipoprotein A-I and its functional consequences.
    Fiévet C; Igau B; Bresson R; Drouin P; Fruchart JC
    Diabete Metab; 1995 Apr; 21(2):95-8. PubMed ID: 7621978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitation of pre beta-HDL-dependent and nonspecific components of the total efflux of cellular cholesterol and phospholipid.
    Kawano M; Miida T; Fielding CJ; Fielding PE
    Biochemistry; 1993 May; 32(19):5025-8. PubMed ID: 8494878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selection of monoclonal antibodies for linear epitopes of an apolipoprotein yields antibodies with comparable affinity for lipid-free and lipid-associated apolipoprotein.
    Curtiss LK; Banka CL
    J Lipid Res; 1996 Apr; 37(4):884-92. PubMed ID: 8732788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Limited proteolysis of high density lipoprotein abolishes its interaction with cell-surface binding sites that promote cholesterol efflux.
    Mendez AJ; Oram JF
    Biochim Biophys Acta; 1997 Jun; 1346(3):285-99. PubMed ID: 9219913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel Apo E-Derived ABCA1 Agonist Peptide (CS-6253) Promotes Reverse Cholesterol Transport and Induces Formation of preβ-1 HDL In Vitro.
    Hafiane A; Bielicki JK; Johansson JO; Genest J
    PLoS One; 2015; 10(7):e0131997. PubMed ID: 26207756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apolipoprotein M predicts pre-beta-HDL formation: studies in type 2 diabetic and nondiabetic subjects.
    Plomgaard P; Dullaart RP; de Vries R; Groen AK; Dahlbäck B; Nielsen LB
    J Intern Med; 2009 Sep; 266(3):258-67. PubMed ID: 19457058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of apolipoprotein A-I- and A-II-containing lipoproteins in a new case of high density lipoprotein deficiency resembling Tangier disease and their effects on intracellular cholesterol efflux.
    Cheung MC; Mendez AJ; Wolf AC; Knopp RH
    J Clin Invest; 1993 Feb; 91(2):522-9. PubMed ID: 8432861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence for the presence of lipid-free monomolecular apolipoprotein A-1 in plasma.
    Miyazaki O; Ogihara J; Fukamachi I; Kasumi T
    J Lipid Res; 2014 Feb; 55(2):214-25. PubMed ID: 24304668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Small discoidal pre-beta1 HDL particles are efficient acceptors of cell cholesterol via ABCA1 and ABCG1.
    Favari E; Calabresi L; Adorni MP; Jessup W; Simonelli S; Franceschini G; Bernini F
    Biochemistry; 2009 Nov; 48(46):11067-74. PubMed ID: 19839639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Action of ciprofibrate in type IIb hyperlipoproteinemia: modulation of the atherogenic lipoprotein phenotype and stimulation of high-density lipoprotein-mediated cellular cholesterol efflux.
    Guerin M; Le Goff W; Frisdal E; Schneider S; Milosavljevic D; Bruckert E; Chapman MJ
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3738-46. PubMed ID: 12915663
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Degradation of pre-beta-high density lipoproteins and their binding activity to human blood monocytes.
    Nakabayashi T; Yamauchi K; Sugano M; Sano K; Tozuka M; Hidaka H
    Ann Clin Lab Sci; 2004; 34(3):287-98. PubMed ID: 15487703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.